Pentagon Rescinds Testosterone Screening Policy Without Explanation

Pentagon rescinds new testosterone screening policy without explanation, after the guidance was posted online for only one day. The U.S. Department of Defense removed the memo that had instructed recruiters to test male enlistees for low testosterone levels as part of a broader health screening initiative. The deletion came with no comment, leaving military officials and policy watchers uncertain about the rationale.

The policy was introduced last year as part of an effort to improve the physical readiness of new soldiers. Low testosterone can impair muscle mass, energy, and recovery, potentially reducing combat effectiveness. Army health officials argued that early identification and treatment would lower injury rates and medical costs. However, the brief announcement sparked debate over privacy, fairness, and the scientific basis for mandatory hormone testing. Critics questioned whether the test could unfairly disqualify otherwise fit candidates and whether the Army had sufficient data to justify the measure.

With the guidance withdrawn, the Pentagon has not yet indicated whether it will replace the policy with a revised version or abandon the idea entirely. Congressional committees that oversee military readiness may call for a briefing, and the Army’s medical board is likely reviewing the evidence that prompted the original memo. If the policy is reinstated, it could affect thousands of recruits and raise legal challenges from advocacy groups. The Army’s next steps will be closely watched by those who view health screening as a tool for maintaining a fit force, as well as by civil liberty advocates who fear intrusive medical checks. The lack of transparency at this stage underscores a broader pattern of rapid policy changes in the military that often outpace public debate.